OBJECTIVE: To evaluate the prevalence of toxoplasmosis and rubella among pregnant women at Ouagadougou in Burkina Faso. METHODS: All patient sera were tested for rubella and toxoplasmosis anti-IgG using commercial ELISA kits (Platelia™ Rubella IgG and Platelia™ Toxo IgG). The presence of anti-rubella and anti-toxoplasmosis IgM in serum samples was tested using commercial ELISA kits Platelia Rubella IgM and Platelia Toxo IgM. RESULTS: Among all the pregnant women tested for toxoplasmosis and rubella, their prevalence were 20.3% and 77.0%, respectively. Pregnant women in the age group of 18-25 years showed the highest frequency of anti-toxoplasmosis (34.5%) and anti-rubella IgG (84.6%). The prevalence of anti-toxoplasma and anti-rubella IgG decreased between 2006 and 2008 from 32.7% to 12.1% and 84.6% to 65.0%, respectively. There was no significant association between age and the mean titer of anti-toxoplasmosis IgG among pregnant women. CONCLUSIONS: The diagnosis of toxoplasmosis and rubella is necessary in pregnant women in Burkina Faso because of the low immunization coverage rate of rubella and the high level of exposure to these two infections which can be harmful to the newborn if contracted by women before the third trimester of pregnancy.
OBJECTIVE: To evaluate the prevalence of toxoplasmosis and rubella among pregnant women at Ouagadougou in Burkina Faso. METHODS: All patient sera were tested for rubella and toxoplasmosis anti-IgG using commercial ELISA kits (Platelia™ Rubella IgG and Platelia™ Toxo IgG). The presence of anti-rubella and anti-toxoplasmosis IgM in serum samples was tested using commercial ELISA kits Platelia Rubella IgM and Platelia Toxo IgM. RESULTS: Among all the pregnant women tested for toxoplasmosis and rubella, their prevalence were 20.3% and 77.0%, respectively. Pregnant women in the age group of 18-25 years showed the highest frequency of anti-toxoplasmosis (34.5%) and anti-rubella IgG (84.6%). The prevalence of anti-toxoplasma and anti-rubella IgG decreased between 2006 and 2008 from 32.7% to 12.1% and 84.6% to 65.0%, respectively. There was no significant association between age and the mean titer of anti-toxoplasmosis IgG among pregnant women. CONCLUSIONS: The diagnosis of toxoplasmosis and rubella is necessary in pregnant women in Burkina Faso because of the low immunization coverage rate of rubella and the high level of exposure to these two infections which can be harmful to the newborn if contracted by women before the third trimester of pregnancy.
Authors: Marc C Tahita; Judith M Hübschen; Zekiba Tarnagda; Da Ernest; Emilie Charpentier; Jacques R Kremer; Claude P Muller; Jean B Ouedraogo Journal: BMC Infect Dis Date: 2013-04-04 Impact factor: 3.090
Authors: Berno Mwambe; Stephen E Mshana; Benson R Kidenya; Anthony N Massinde; Humphrey D Mazigo; Denna Michael; Charles Majinge; Uwe Groß Journal: Parasit Vectors Date: 2013-08-06 Impact factor: 3.876
Authors: Berno Mwambe; Mariam M Mirambo; Stephen E Mshana; Anthony N Massinde; Benson R Kidenya; Denna Michael; Domenica Morona; Charles Majinge; Uwe Groß Journal: BMC Pregnancy Childbirth Date: 2014-03-03 Impact factor: 3.007
Authors: Illuminata Machumi; Mariam M Mirambo; Deodatus Ruganuza; Peter Rambau; Anthony N Massinde; Albert Kihunrwa; Stephen E Mshana; Domenica Morona Journal: East Afr Health Res J Date: 2017-07-01
Authors: Aliasgher M Saajan; Mramba Nyindo; Joshua G Gidabayda; Mohammed S Abdallah; Shaneabbas H Jaffer; Aliasgher G Mukhtar; Tima M Khatibu; Rune Philemon; Grace D Kinabo; Blandina T Mmbaga Journal: East Afr Health Res J Date: 2017-07-01